XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity-based compensation - Value Appreciation Rights (Details) - VARs - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Number of Units    
Outstanding, beginning of period (in shares) 7,190  
Exercised (in shares) (1,587)  
Forfeited (in shares) (1,058)  
Outstanding, end of period (in shares) 4,546 7,190
Value appreciation right awards vested and expected to vest (in shares) 2,883  
Weighted Average Exercise Price    
Outstanding, beginning of period (in dollars per shares) $ 0.50  
Exercised (in dollar per share) 0.50  
Forfeited (in dollars per share) 0.50  
Outstanding, end of period (in dollars per shares) 0.50 $ 0.50
Value appreciation right awards vested and expected to vest (in dollars per shares) $ 0.50  
Total Intrinsic Value    
Outstanding, beginning of period, intrinsic value $ 136,038  
Outstanding, end of period, intrinsic value 25,000 $ 136,038
Value appreciation right awards vested and expected to vest $ 15,859  
Weighted Average Remaining Contractual Life (in years)    
Outstanding (in years) 6 years 9 months 18 days 7 years 7 months 6 days
Value appreciation right awards vested and expected to vest (in years) 6 years 9 months 18 days